TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Great. Thanks. Thanks, everyone, for joining in -- for tuning into the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. And our next presenting company this afternoon is TG Therapeutics. And it's my pleasure to welcome CEO, Mike Weiss, to tell us a little bit about the company. (Operator Instructions)
With that, Mike, thanks again for sharing some of your time with us out here.
Yes. Thanks, Eric. I really appreciate it. I want to specifically thank JPMorgan. After 8 years of presenting on a Thursday, when it doesn't matter at all, I got the Tuesday slot. So really appreciate it. So thanks all, and thanks, everyone, for joining us.
So on Slide 2, I'll be making some forward-looking statements. I do encourage folks who are interested in TG Therapeutics to review our public disclosure documents available on the Internet.
Slide 3. So just
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |